The hormone replacement therapy market has been disrupted by the development of male hormone therapy used to treat male hypogonadism, a condition that impacts testosterone production in men. Low testosterone production in men is linked to infertility, osteoporosis, loss of facial hair, and impotency.The treatment of menopausal symptoms continues to be the most significant trend in the market. Menopause symptoms such as hot flashes and vaginal atrophy have been reported to have considerably lessened in women after they are treated with hormonal replacement therapy. Women are also approaching hormone therapy for anti-aging, which is creating further opportunities for the hormone replacement therapy market. During the forecast period of 2019-2025, the [FURL=https://www.industryarc.com/PressRelease/1815/Hormonal-Replacement-Therapy-Market-Research-Analysis.html]Hormonal Replacement Therapy Market[/FURL] will grow with a CAGR of 7.5, and it earned a revenue of $16.5 billion in 2018.
Improved Drug Delivery Systems Holds Growth Opportunities for the Hormonal Replacement Therapy Market
The healthcare industry is undergoing a visible transformation of drug delivery as a growing number of technologies with enhanced results come into being. The hormonal replacement therapy market has conventionally stuck to the oral administration of hormones, but this is changing now with improved drug delivery systems. A wide range of available options increases consumers as they can choose their preferred kind of hormone therapy delivery method.
Browse Hormonal Replacement Therapy Market Report Link:
[FURL]https://www.industryarc.com/PressRelease/1815/Hormonal-Replacement-Therapy-Market-Research-Analysis.html[/FURL]
Hormone Replacement Therapy Market: Key Market Players
Key companies operating in the hormone replacement therapy market are expending their resources on R&D that could further increase the scope of the market. One of the key areas of focus includes the reduction of side effects in women and men undergoing hormonal replacement therapy. Another area includes removing the stigma associated with women undergoing hormonal therapy for the reduction of menopausal symptoms. These key areas will be pivotal in shaping the growth of the hormone replacement therapy market in the upcoming years. The key companies responsible for this growth are Eli Lilly, Mylan Laboratories, Roche, Pfizer, Abbott Laboratories, Novo Nordisk, Novartis, Merck Serono, and Bayer Healthcare.
Talk to one of our sales representative about the full report by providing your details in the link below:
[FURL]https://www.industryarc.com/support.php?id=15880[/FURL]
About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.